TX200-TR101
TX200 KT02
Phase 2 mab active
Quick answer
TX200-TR101 for Kidney Transplant Rejection is a Phase 2 program (mab) at SANGAMO THERAPEUTICS, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SANGAMO THERAPEUTICS, INC
- Indication
- Kidney Transplant Rejection
- Phase
- Phase 2
- Modality
- mab
- Status
- active